Alfuzosin

ADVERTISEMENT

Identification

Molecular formula
C19H27N5O2
CAS Number
81403-68-1
IUPAC Name
2-(4-allylpiperazin-1-yl)-6,7-dimethoxy-quinazolin-4-amine
Molecular Weight
389.47g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.3000g/cm3
Synonyms
QUINAZOSIN
Interesting facts

Interesting Facts About 2-(4-allylpiperazin-1-yl)-6,7-dimethoxy-quinazolin-4-amine

This fascinating compound belongs to the class of quinazoline derivatives, which are known for their diverse biological activities. The structure of 2-(4-allylpiperazin-1-yl)-6,7-dimethoxy-quinazolin-4-amine showcases a remarkable interplay between its various functional groups, which contributes to its potential therapeutic properties.

Biological Significance

Quinazoline derivatives have attracted considerable interest in medicinal chemistry due to their potential as:

  • Anticancer Agents: Many quinazoline compounds have demonstrated significant activity against various cancer cell lines.
  • Antiparasitic Activity: Some structures show promise in inhibiting parasite growth, making them candidates for treating diseases like malaria.
  • Neurological Effects: The allylpiperazine moiety may enhance the compound's ability to interact with neurotransmitter systems, suggesting potential applications in neurology.

Chemical Relationships

The presence of methoxy groups is noteworthy as they can influence the compound's solubility and overall biological activity. Methoxy groups often enhance the electron-donating properties of aromatic systems, potentially increasing binding affinity to biological targets.

Research Implications

With ongoing research, this compound stands as a reminder of the importance of structure-activity relationships (SAR) in drug design. Scientists constantly seek to optimize these properties through:

  • Modifications of functional groups to improve efficacy and reduce side effects.
  • Synthetic pathways that aim for more sustainable and cost-effective production.

As with many compounds in medicinal chemistry, the journey from laboratory synthesis to clinical application can be long and complex. However, with its unique structural features, 2-(4-allylpiperazin-1-yl)-6,7-dimethoxy-quinazolin-4-amine represents a promising candidate for future advances in drug discovery.

ADVERTISEMENT